Pfizer, Inc. Press Releases

PFE 
$31.15
*  
0.05
0.16%
Get PFE Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Papa John’s Accelerates International Growth in India
11/24/2014 8:30:00 PM - Business Wire


Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology
11/19/2014 8:00:00 AM - Business Wire


Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research
11/18/2014 9:00:00 AM - PR Newswire


TRUMENBA® (Meningococcal Group B Vaccine) is Now Available
11/18/2014 8:30:00 AM - Business Wire


Nodality, Inc. Announces Data Presentation from Collaborative Program with UCB at American College of Rheumatology 2014 Annual Meeting
11/18/2014 8:00:00 AM - Business Wire


Nodality, Inc. Announces Data Presentations from Systemic Lupus Erythematosus Collaborative Programs at American College of Rheumatology 2014 Annual Meeting
11/17/2014 8:30:00 AM - Business Wire


Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)
11/17/2014 8:00:00 AM - GlobeNewswire


Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
11/17/2014 3:40:00 AM - Business Wire


Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
11/17/2014 2:53:00 AM - Business Wire


Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana® Press, for Women Most in Need in the World’s Poorest Countries
11/13/2014 11:00:00 AM - Business Wire
▲1.83 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting
11/12/2014 8:00:00 AM - Business Wire
▲2.84 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Insider Trading Recap for AK Steel, Pfizer, Chesapeake Energy, Plug Power, Twitter, and RF Micro Devices
11/11/2014 8:45:00 AM - PR Newswire


Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference
11/5/2014 11:00:00 AM - Business Wire
▲3.49 % Price Change since this news event. The Volume Ratio is 0.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
10/29/2014 2:44:00 PM - Business Wire
▲5.59 % Price Change since this news event. The Volume Ratio is 5.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder
10/29/2014 8:30:00 AM - Business Wire
▲7.04 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PFIZER REPORTS THIRD-QUARTER 2014 RESULTS
10/28/2014 7:00:00 AM - Business Wire
▲7.12 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


DURECT Provides Update on REMOXY® and POSIDUR™ Programs
10/27/2014 8:05:00 AM - PR Newswire


Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII
10/27/2014 8:00:00 AM - Business Wire
▲6.68 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend
10/23/2014 4:05:00 PM - Business Wire
▲8.92 % Price Change since this news event. The Volume Ratio is 0.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Wins SUTENT® Patent Case In Delaware District Court
10/23/2014 8:00:00 AM - Business Wire
▲9.68 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S.
10/20/2014 9:00:00 AM - PR Newswire


FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII
10/17/2014 4:38:00 PM - Business Wire
▲12.37 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
10/13/2014 8:00:00 AM - Business Wire
▲7.08 % Price Change since this news event. The Volume Ratio is 1.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™
10/10/2014 8:00:00 AM - Business Wire
▲7.79 % Price Change since this news event. The Volume Ratio is 1.53.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer
10/8/2014 8:30:00 AM - Business Wire